Antitumor activity in mice of an immunotoxin made with anti-transferrin receptor and a recombinant form of Pseudomonas exotoxin
- PMID: 2510169
- PMCID: PMC298319
- DOI: 10.1073/pnas.86.21.8545
Antitumor activity in mice of an immunotoxin made with anti-transferrin receptor and a recombinant form of Pseudomonas exotoxin
Abstract
LysPE40 is a modified form of Pseudomonas exotoxin that lacks the cell-binding domain and has a chemically reactive lysine residue near the amino terminus. LysPE40 is made in Escherichia coli and secreted into the medium from which it is readily purified. Two immunotoxins were constructed by coupling LysPE40 to an antibody to the human transferrin receptor (TFR) or to an antibody to the human interleukin-2 receptor. These immunotoxins were selectively cytotoxic to receptor-bearing cells in tissue culture. Anti-TFR-LysPE40 given intraperitoneally to mice appeared rapidly in the blood and caused regression of A431 tumors growing as subcutaneous xenografts. These results show that it is possible to cause regression of a solid carcinoma by an immunotoxin if proper targeting can be achieved.
Similar articles
-
Antitumor effects of B3-PE and B3-LysPE40 in a nude mouse model of human breast cancer and the evaluation of B3-PE toxicity in monkeys.Cancer Res. 1992 Jun 1;52(11):3189-93. Cancer Res. 1992. PMID: 1591729
-
Anti-tumor activities of immunotoxins made of monoclonal antibody B3 and various forms of Pseudomonas exotoxin.Proc Natl Acad Sci U S A. 1991 Apr 15;88(8):3358-62. doi: 10.1073/pnas.88.8.3358. Proc Natl Acad Sci U S A. 1991. PMID: 2014255 Free PMC article.
-
Recombinant immunotoxins containing anti-Tac(Fv) and derivatives of Pseudomonas exotoxin produce complete regression in mice of an interleukin-2 receptor-expressing human carcinoma.Blood. 1994 Jan 15;83(2):426-34. Blood. 1994. PMID: 8286741
-
Quantification of immunotoxin number for complete therapeutic response.Methods Mol Biol. 2001;166:111-23. doi: 10.1385/1-59259-114-0:111. Methods Mol Biol. 2001. PMID: 11217362 Review. No abstract available.
-
Pseudomonas exotoxin--immunotoxins.Cancer Treat Res. 1988;37:161-73. doi: 10.1007/978-1-4613-1083-9_11. Cancer Treat Res. 1988. PMID: 2908624 Review.
Cited by
-
Targeting Receptors on Cancer Cells with Protein Toxins.Biomolecules. 2020 Sep 17;10(9):1331. doi: 10.3390/biom10091331. Biomolecules. 2020. PMID: 32957689 Free PMC article. Review.
-
Single-chain immunotoxins directed at the human transferrin receptor containing Pseudomonas exotoxin A or diphtheria toxin: anti-TFR(Fv)-PE40 and DT388-anti-TFR(Fv).Mol Cell Biol. 1991 Apr;11(4):2200-5. doi: 10.1128/mcb.11.4.2200-2205.1991. Mol Cell Biol. 1991. PMID: 2005905 Free PMC article.
-
Therapeutic effect of ansamitocin targeted to tumor by a bispecific monoclonal antibody.Jpn J Cancer Res. 1992 Jul;83(7):761-8. doi: 10.1111/j.1349-7006.1992.tb01977.x. Jpn J Cancer Res. 1992. PMID: 1517150 Free PMC article.
-
Recombinant anti-erbB2 immunotoxins containing Pseudomonas exotoxin.Proc Natl Acad Sci U S A. 1992 Jul 1;89(13):5867-71. doi: 10.1073/pnas.89.13.5867. Proc Natl Acad Sci U S A. 1992. PMID: 1352878 Free PMC article.
-
Monoclonal antibody C242-Pseudomonas exotoxin A. A specific and potent immunotoxin with antitumor activity on a human colon cancer xenograft in nude mice.J Clin Invest. 1992 Aug;90(2):405-11. doi: 10.1172/JCI115875. J Clin Invest. 1992. PMID: 1644913 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources